Inhibition of MAO by  -carbolinium halides.
D000818:Animals; D001665:Binding Sites; D001921:Brain / Q000187:drug effects; D002247:Carbon Isotopes; D002415:Cats; D006219:Halogens / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects; D051379:Mice; D008930:Mitochondria, Liver / Q000201:enzymology; D008931:Mitochondria, Muscle / Q000201:enzymology; D008995:Monoamine Oxidase / Q000302:isolation & purification; D008996:Monoamine Oxidase Inhibitors; D009206:Myocardium / Q000201:enzymology; D010293:Pargyline / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats; D013329:Structure-Activity Relationship; D014363:Tryptamines / Q000494:pharmacology
D002247:Carbon Isotopes; D006219:Halogens; D007211:Indoles; D008996:Monoamine Oxidase Inhibitors; D011725:Pyridines; D014363:Tryptamines; D010293:Pargyline; D008995:Monoamine Oxidase